http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4490383

Outgoing Links

Predicate Object
contentType Journal Article|Meta-Analysis|Research Support, Non-U.S. Gov't
issn 1756-9966
0392-9078
issueIdentifier 1
pageRange 54-
publicationName Journal of experimental & clinical cancer research : CR
startingPage 54
bibliographicCitation Cuppone F, Bria E, Vaccaro V, Puglisi F, Fabi A, Sperduti I, Carlini P, Milella M, Nisticò C, Russillo M, Papaldo P, Ferretti G, Aapro M, Giannarelli D, Cognetti F. Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. Journal of Experimental & Clinical Cancer Research. 2011 May 12;30(1):54. doi: 10.1186/1756-9966-30-54.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e75d665606d7b62ad20611f909c08683
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f93e87dc0b2894f49a28ef9060e757e3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02dfa69e840e5f3c267be5dc03076ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94f9e9b577b9006683f103a8c07c912b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0573-4938
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7df44e172afe5f1591c35ddb59a0ff83
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98a849032b6d34ae4324d53d5b3590e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82ff2c3650e3e2c1154902f4f1b81917
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0758-8033
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2333-704X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2022-9446
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_854d980800ce0d4193dee839a5ebddbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e8a3086776ce56cf84186f1bb4ff38
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2379-5550
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e71579094eb73d51d18236ee4ef00bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f22b75ee591298731652e372890d5936
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_058ddd46d72231ad5be85bd9b21852d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a8c93e1c1f17892cc957006fe589c52
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ad20b916b2f53d4a033e384e78cdfab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2271-6427
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43e79a2e7dc68f0f9087220f5fe6f244
date 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/1756-9966-30-54
https://pubmed.ncbi.nlm.nih.gov/21569417
https://pubmed.ncbi.nlm.nih.gov/PMC3120715
isPartOf https://portal.issn.org/resource/ISSN/1756-9966
https://portal.issn.org/resource/ISSN/0392-9078
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20601
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
discusses http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0443627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a508fb1b5037213c2bb0d9a5243706d0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10523
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128658409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248175226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606

Total number of triples: 66.